Related Experiment Videos
[False negative Pap smears in a Danish material].
Dorthe Ejersbo1, Maj-Britt Dahl, Berit Hølund
1Patologisk Institut, Odense Universitetshospital, DK-5000 Odense.
Ugeskrift for Laeger
|July 5, 2003
Summary
Cervical cancer screening aims to reduce cases and treat precursor lesions. This study found a 22% false negative rate in Pap smears, primarily due to sampling errors, highlighting the need for improved training and liquid-based cytology.
Area of Science:
- Gynecologic Oncology
- Cytopathology
- Public Health Screening
Context:
- Cervical cancer screening programs aim to reduce incidence and mortality by detecting precancerous lesions.
- Effective screening relies on accurate Pap smear analysis and interpretation.
- Previous studies indicate variability in screening accuracy, necessitating local assessments.
Purpose:
- To determine the false negative rate of cervical cancer screening in the County of Funen.
- To identify the primary causes of false negative Pap smear results.
- To propose strategies for reducing false negative rates and improving screening efficacy.
Summary:
- A retrospective analysis of 551 Pap smears revealed a 22% false negative rate for the year 1991.
- Sampling errors accounted for 81% of false negatives, with interpretation and screening errors comprising the remainder (4.6%).
- Key causes of false negatives include specific cytological cell patterns, emphasizing the need for enhanced staff training.
Impact:
- Findings underscore the importance of rigorous training and continuous education for cytological staff.
- Implementing liquid-based cytology is recommended to improve sample quality and screening accuracy.
- Reducing false negative rates can lead to earlier detection and treatment of cervical dysplasia, improving patient outcomes.